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Abstract
Background. To establish a patient-oriented outcome measure 
for cervical myelopathy, a subcommittee of the Japanese 
Orthopaedic Association (JOA) developed a new scoring 
system to evaluate the overall clinical status of patients, which 
could be completed by patients themselves. The subcommittee 
completed three large-scale studies to select and modify ques-
tions derived from various preexisting outcome measures 
including Short Form-36, and then fi nalized and validated the 
questionnaire, which comprised 24 questions.
Methods. The fi nalized questionnaire was administered to 
369 patients with cervical myelopathy due to disc herniation, 
spondylosis, or ossifi cation of posterior longitudinal ligament 
by randomly selected board-certifi ed spine surgeons. Patients 
with different severities of myelopathy were included to insure 
accuracy and responsiveness of this questionnaire against 
patients’ different neurological status.
Results. Data of 236 patients were employed and were sub-
jected to rigorous statistical analyses. There was no question 
that was diffi cult to answer and distribution of answers for 
each question was not concentrated to one choice, indicating 
the appropriateness of all 24 questions. Results of factor anal-
ysis suggested that the 24 questions could be divided into 
fi ve different factors or functional domains. The factors were 
defi ned as follows: factor 1, lower extremity function; factor 2, 
quality of life; factor 3, cervical spine function; factor 4, bladder 
function; and factor 5, upper extremity function. Finally, equa-
tions that would yield scores for the fi ve factors were assem-
bled. The score to be used to represent the degree of patients’ 
disability or status in each domain can be calculated by mul-
tiplying prefi xed numbers of selected answers to questions by 
preassigned coeffi cients. Coeffi cients were defi ned to make 
the minimum score 0 and the maximum score 100.
Conclusions. We have successfully established a question-
naire that is able to demonstrate the status of patients suffer-
ing cervical myelopathy from fi ve different aspects represented 
by fi ve intuitive numerical scores. The fi nal issue to be con-
fi rmed is the responsiveness of this questionnaire to changes 
in patients’ status after various surgical and nonsurgical 
treatments.
Introduction
The Japanese Orthopaedic Association scoring system 
for the evaluation of cervical myelopathy (JOA score) 
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was fi rst established by a committee of the JOA chaired 
by Hirabayashi.1 Since then, this scoring system has 
been accepted universally in Japan as a tool to measure 
the outcomes of surgical and nonsurgical treatments 
for various cervical spinal disorders that cause cervical 
myelopathy. The JOA score fi rst appeared in the English 
literature in 1980 when Hirabayashi published an article 
describing surgical results in patients with ossifi cation 
of the posterior longitudinal ligament of the cervical 
spine (OPLL) that underwent expansive open-door 
laminoplasty.2 The JOA score underwent the fi rst revi-
sion in 1994 to refl ect the defi cits in shoulder and elbow 
functions, which are often caused by cervical root lesions, 
and this revised version was offi cially translated into 
English.3 Various modifi ed versions of the JOA score 
have also been introduced in the western countries.4–6 
The JOA score is a disease-specifi c and physician-
oriented system that mainly assesses the neurological 
status of the patient and enables surgeons to compare 
the changes in the neurological status of the patient 
before and after certain treatments. Due to emerging 
needs to evaluate the impairments in patients’ activities 
of daily living (ADL), which is related directly to their 
quality of life (QOL), various patient-oriented outcome 
measures, for example, the Short Form (SF)-36, have 
been developed and adopted into clinical practices in 
different medical fi elds.7 To take up such needs, the JOA 
together with the Japanese Society of Spine Surgery and 
Related Research (JSSR), formerly called the Japanese 
Spine Research Society (JSRS), has appointed several 
members of the Clinical Outcomes Committee of the 
JOA to organize a subcommittee, the aim of which is 
to develop a completely new patient-oriented scoring 
system for the evaluation of clinical results in patients 
with back pain and cervical myelopathy. The subcom-
mittee decided to construct a self-rating questionnaire 
that could be fi lled out by patients themselves. 
Candidates of the questions to be included in the 
questionnaire were selected and modifi ed from various 
preexisting outcome measures including the SF-36, the 
Rolland and Morris Disability Questionnaire, and the 
Oswestry Disability Index.8,9 The subcommittee com-
pleted three large-scale studies to select and validate the 
questions that would ultimately become parts of the 
new JOA scoring system and as a result, the question-
naires including 25 and 24 questions for the evaluation 
of back pain and cervical myelopathy respectively were 
fi nalized.10–12 In the present study, the cervical version of 
the fi nalized questionnaires was administered to patients 
with cervical myelopathy of different severity to insure 
the accuracy and responsiveness of this questionnaire 
and the obtained data were subjected to factor analysis 
in order to divide the 24 questions into different func-
tional domains. The titles of the domains were desig-
nated according to the context of the questions in each 
domain. Finally, the equations that would yield scores 
based on the answers to the questions, selected by the 
patients, in the different domains were established. The 
scores would represent the degree of patient disability 
in the functional domains.
Table 1. Sex and age distribution of patients
Sex
Age groups 
(years)
Severity of myelopathy
TotalMild Moderate Severe NA
Male 20–29 0 0 1 1
30–39 5 6 3 14
40–49 5 5 8 18
50–59 16 18 6 1 41
60–69 24 26 9 59
70–79 7 9 7 23
80–89 3 1 2 6
>90 0 0 0 0
Total 60 65 36 1 162
Female 20–29 0 0 0 0
30–39 2 1 0 3
40–49 3 6 0 9
50–59 4 8 2 14
60–69 11 8 4 23
70–79 5 8 7 20
80–89 2 2 1 5
>90 0 0 0 0
Total 27 33 14 74
Total 87 98 50 1 236
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Materials and methods
The subcommittee randomly chose 369 out of 829 
board-certifi ed spine surgeons who were registered in 
the JSSR database and asked them to participate in the 
present survey. Each surgeon was asked to administer 
the questionnaire to patients with cervical myelopathy 
due to disc herniation, spondylosis, or OPLL. The sur-
geons were required to include at least one patient each 
with mild, moderate, and severe myelopathy according 
to the discretion of each surgeon. Patients with (1) 
myelopathy due to nondegenerative diseases, such as 
trauma, tumor, and rheumatoid arthritis; (2) other mus-
culoskeletal diseases that would affect the evaluation of 
myelopathy; (3) diffi culties fi lling the questionnaire due 
to their specifi c physical (e.g., defects or impairments in 
the limbs) or mental conditions (e.g., dementia, disori-
entation); and (4) a history of previous spinal surgery, 
were excluded from the analysis. Those who partici-
pated in our previous studies were also excluded. The 
surgeons were also asked to assess the neurological 
status of the patients using the original JOA scoring 
system. This study was approved by the Ethics Commit-
tee of the JSSR, and informed consent was obtained 
Table 2. Distribution of scores for subdomains in original scoring system of Japanese Orthopaedic Association
Domain Function Score Response number
Motor Upper extremity: feeding
 Impossible 0 5
 Severe 1 22
 Moderate 2 56
 Mild 3 92
 Normal 4 61
Motor Upper extremity: shoulder and elbow function
 Severe −2 8
 Moderate −1 14
 Mild −0.5 45
 Normal 0 166
 Unknown 3
Motor Lower extremity: gait
 Impossible 0 9
0.5 1
 Severe 1 26
1.5 23
 Moderate 2 39
2.5 20
 Mild 3 59
 Normal 4 59
Sensory Upper extremity
 Severe 0 9
0.5 40
 Moderate 1 111
 Mild 1.5 60
 Normal 2 16
Sensory Trunk
 Severe 0 1
0.5 5
 Moderate 1 39
 Mild 1.5 26
 Normal 2 165
 Unknown
Sensory Lower extremity
 Severe 0 4
0.5 24
 Moderate 1 69
 Mild 1.5 46
 Normal 2 93
Bladder Urinary dysfunction
 Severe 0 3
 Moderate 1 40
 Mild 2 55
 Normal 3 138
 Unknown
n = 236
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from each subject. The completed questionnaires and 
the results of the original JOA scoring system were col-
lected and sent to the independent central organization 
where biostatisticians compiled the results and input 
patient data into a spreadsheet. Rigorous statistical 
analyses including factor analysis were performed using 
SPSS software (Version 12, SPSS, Chicago, IL, USA).
Results
Three hundred and sixty-nine patients were initially 
recruited for this survey. Among them, 106 patients 
were excluded because they had other musculoskeletal 
disorders that could affect the evaluation of cervical 
myelopathy. Most of them had nonspecifi c low-back 
pain without neurological symptoms (n = 70) and mild 
knee joint pain due to osteoarthritis (n = 22). Twenty-six 
patients gave no answers to one or more questions and 
were also excluded. One other patient was excluded 
because of the discretion of the surgeon in charge. The 
data of the remaining 236 patients were employed. The 
sex and age distributions of patients and the distribu-
tions of the scores for different subdomains in the origi-
nal JOA scoring system are given in Tables 1 and 2. 
Because the majority of the excluded patients were 
those having other musculoskeletal diseases due to 
spondylosis or osteoarthritis, the average age was sig-
nifi cantly higher in the excluded patients than those that 
were included. The average scores for shoulder/elbow 
function and lower motor function in the JOA scoring 
system were signifi cantly lower in the excluded patients 
than those for the included subjects.
The incidence of unanswered questions was less than 
5%, indicating that there was no question that was dif-
fi cult to answer. There also was no question for which 
the distribution of the answer was concentrated to one 
choice (Table 3), indicating the appropriateness of all 24 
questions.
Results of factor analysis revealed that there were six 
common factors whose eigenvalues exceeded 1.0, which 
are thought to be the factor having signifi cant contribu-
tions to the result. We decided to employ the fi rst fi ve 
factors because the cumulative contribution rate of the 
fi rst fi ve factors reached 60% and the contribution of 
the sixth factor was less than 5% (Table 4).
According to the calculation of the factor loadings 
after orthogonal rotation using the direct oblimin 
method with the Kaiser normalization, correlations 
among the 24 questions and the selected fi ve factors 
were reexamined. When the maximum factor loading of 
a question exceeded 0.40, that question was supposed 
to be correlated with the factor. All 24 questions were 
judged to have correlation with at least one of the fi ve 
Table 3. Distribution of answers for 24 questions
Question
Response
1 2 3 4 5
Q1-1 108 (45.8) 103 (43.6) 25 (10.6)
Q1-2 171 (72.5) 56 (23.7) 9 (3.8)
Q1-3 154 (65.3) 49 (20.8) 23 (9.7) 10 (4.2)
Q1-4 107 (45.3) 82 (34.7) 24 (10.2) 15 (6.4)  8 (3.4)
Q1-5 107 (45.3) 72 (30.5) 57 (24.2)
Q1-6 153 (64.8) 49 (20.8) 19 (8.1) 12 (5.1)  3 (1.3)
Q1-7 77 (32.6) 114 (48.3) 45 (19.1)
Q1-8 127 (53.8) 83 (35.2) 26 (11.0)
Q1-9 143 (60.6) 73 (30.9) 20 (8.5)
Q1-10 120 (50.8) 86 (36.4) 30 (12.7)
Q1-11 140 (59.3) 70 (29.7) 26 (11.0)
Q1-12 161 (68.2) 53 (22.5) 22 (9.3)
Q1-13 91 (38.6) 90 (38.1) 55 (23.3)
Q2-1 6 (2.5) 14 (5.9) 87 (36.9) 100 (42.4) 29 (12.3)
Q2-2 48 (20.3) 113 (47.9) 75 (31.8)
Q2-3 43 (18.2) 126 (53.4) 67 (28.4)
Q2-4 46 (19.5) 98 (41.5) 92 (39.0)
Q2-5 25 (10.6) 45 (19.1) 95 (40.3) 51 (21.6) 20 (8.5)
Q2-6 38 (16.1) 49 (20.8) 75 (31.8) 50 (21.2) 24 (10.2)
Q2-7 24 (10.2) 31 (13.1) 105 (44.5) 53 (22.5) 23 (9.7)
Q2-8 24 (10.2) 38 (16.1) 113 (47.9) 40 (16.9) 21 (8.9)
Q2-9 14 (5.9 ) 46 (19.5) 104 (44.1) 50 (21.2) 22 (9.3)
Q2-10 26 (11.0) 68 (28.8) 51 (21.6) 56 (23.7) 35 (14.8)
Q2-11 38 (16.1) 76 (32.2) 73 (30.9) 36 (15.3) 13 (5.5)
Numbers given in parentheses are percentages of the total response
M. Fukui et al.: JOACEMQ: part 4 29
Table 4. Results of factor analysis
Factor Eigenvalue Contribution rate (%)
Cumulative 
contribution rate (%)
 1 8.86 36.9 36.9
 2 2.02 8.4 45.3
 3 1.56 6.5 51.8
 4 1.36 5.6 57.5
 5 1.20 5.0 62.5
 6 1.08 4.5 67.0
 7 0.81 3.4 70.3
 8 0.71 3.0 73.3
 9 0.67 2.8 76.1
10 0.62 2.6 78.7
11 0.53 2.2 80.9
12 0.51 2.1 83.0
13 0.48 2.0 85.0
14 0.43 1.8 86.8
15 0.41 1.7 88.5
16 0.40 1.7 90.2
17 0.38 1.6 91.7
18 0.35 1.5 93.2
19 0.32 1.4 94.6
20 0.30 1.3 95.8
21 0.28 1.2 97.0
22 0.27 1.1 98.1
23 0.24 1.0 99.1
24 0.22 0.9 100.0
n = 236
Bold typeface indicates eigenvalues over 1.0
factors, except for Q1-4 and Q1-12. Q1-4 had relatively 
higher factor loadings for both factor 1 and 5 and this 
question was judged to be correlated with both factors. 
Q1-12 was fi rst judged to be weakly correlated with 
factor 5 with a factor loading of 0.37; however, the com-
mittee decided to correlate this question also to factor 
3 after reading the context of the question and given 
that the factor loading of 0.32 was also moderately high 
(Table 5).
According to the interpretations of the context of the 
questions that were divided into the fi ve factors, each 
factor was categorized as follows; factor 1: lower extrem-
ity function; factor 2: quality of life; factor 3: cervical 
spine function; factor 4: bladder function; and factor 5: 
upper extremity function.
To establish an equation to calculate the individual 
score for each factor/domain that would intuitively indi-
cate the status of a patient with regard to the designated 
function, the questions that had the maximum absolute 
factor loading value were used to calculate the score for 
the factor. For example, Q1-5 was used to calculate the 
score for factor 1 (lower extremity function), because 
the factor loading of this question for factor 1 was mark-
edly larger (0.58) than those for the other four factors 
(−0.10, −0.14, −0.12, 0.11). As described above, Q1-4 and 
Q1-12 were used to calculate the scores for both factors 
1 and 5, and 3 and 5, respectively (Table 5). The score 
was derived by multiplying the prefi xed number of the 
Table 5. Factor loading after orthogonal rotation
Question
Factors
1 2 3 4 5
Q1-5 0.58 −0.10 −0.14 −0.12 0.11
Q1-4 0.55 0.05 −0.08 −0.12 0.40
Q2-3 -0.39 0.25 0.16 0.18 −0.04
Q2-4 -0.39 0.24 0.10 0.33 −0.09
Q2-2 -0.52 0.20 0.13 0.24 −0.03
Q2-7 0.10 0.79 0.00 0.08 −0.01
Q2-8 0.14 0.73 0.06 0.12 −0.06
Q2-11 −0.01 0.68 −0.21 0.03 0.01
Q2-6 0.05 0.55 0.25 −0.06 −0.06
Q2-5 −0.27 0.39 0.19 0.04 −0.13
Q2-10 0.23 -0.49 0.08 −0.10 0.15
Q2-1 0.12 -0.60 −0.04 0.01 0.09
Q2-9 0.13 -0.66 −0.13 0.10 −0.06
Q1-11 −0.02 0.03 -0.57 −0.24 0.10
Q1-13 0.05 −0.06 -0.75 0.00 0.05
Q1-10 0.04 −0.01 -0.87 0.07 −0.06
Q1-12 0.10 0.04 −0.32 −0.21 0.37
Q1-9 0.08 −0.05 −0.07 -0.43 −0.01
Q1-7 0.14 −0.04 0.09 -0.53 −0.03
Q1-6 0.00 0.02 0.01 -0.58 0.03
Q1-8 −0.11 0.01 −0.06 -0.61 0.00
Q1-2 0.12 0.02 0.02 0.10 0.73
Q1-1 0.24 −0.13 0.01 0.02 0.60
Q1-3 −0.27 −0.11 −0.05 −0.11 0.60
Method of factor extraction: unweighted least-squares method. Or-
thogonal rotation: direct oblimin method with Kaiser normalization
Bold typeface indicates absolute value of the factor loading of more 
than 0.35
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with different spinal disorders. We also took extra care 
to maintain relevance to the original JOA scoring 
systems by carefully assessing the correlation between 
the new and original systems. The new questionnaires 
have been revised several times and underwent many 
validation processes using rigorous statistical analyses. 
As a result, 24 questions were selected as the items of 
the fi nalized questionnaires for back pain and cervical 
myelopathy.10–13
In the present study, patients with different severity 
of cervical myelopathy were examined using the cervi-
cal version of the questionnaires to insure the accuracy 
and responsiveness of this questionnaire against various 
neurological states of the patient. Factor analysis was 
used to divide the 24 questions into different factorial 
domains, and the domains were categorized by inter-
Table 6. Coeffi cients for calculation of severity score
Question
Factors
1
Lower extremity 
function
2
Quality of 
life
3
Cervical spine 
function
4
Bladder 
function
5
Upper extremity 
function
Q1-1 −10
Q1-2 −15
Q1-3 −5
Q1-4 −10 −5
Q1-5 −10
Q1-6 −10
Q1-7
 −5
Q1-8 −10
Q1-9
 −5
Q1-10 −20
Q1-11 −10
Q1-12
 −5 −5
Q1-13 −15
Q2-1 −3
Q2-2 15
Q2-3 5
Q2-4 5
Q2-5 2
Q2-6 2
Q2-7 5
Q2-8 4
Q2-9 −3
Q2-10 −2
Q2-11 3
Table 7. Equations to calculate scores for different factors
Factor Equation
1 Lower extremity function (Q1-4 × 10 + Q1-5 × 10 + Q2-2 × 15 + Q2-3 × 5 + Q2-4 × 5 − 45) × 100 ÷ 105
2 Quality of life (Q2-1 × 3 + Q2-5 × 2 + Q2-6 × 2 + Q2-7 × 5 + Q2-8 × 4 + Q2-9 × 3 + Q2-10 × 2+ Q2-11 × 3 
− 24) × 100 ÷ 96
3 Cervical spine function (Q1-10 × 20 + Q1-11 × 10 + Q1-12 × 5 + Q1-13 × 15 − 50)
4 Bladder function (Q1-6 × 10 + Q1-7 × 5 + Q1-8 × 10 + Q1-9 × 5 − 30) × 100 ÷ 80
5 Upper extremity function (Q1-1 × 10 + Q1-2 × 15 + Q1-3 × 5 + Q1-4 × 5 + Q1-12 × 5 − 40) × 100 ÷ 95
answer, selected by the patient, by the coeffi cient that 
were defi ned to make the difference between the 
minimum and maximum scores to be approximately 100 
points (Table 6). The additional coeffi cients were also 
assigned to adjust the minimum score to be 0 and the 
maximum score to be 100. The fi nal equations for the 
scores for the fi ve domains are shown in Table 7.
Discussion
In our previous studies, the questionnaires were con-
structed by referring to various preexisting outcome 
measures including the SF-36, the Roland and Morris 
Disability Questionnaire, and the Oswestry Disability 
Index,7–9 which have commonly been used for patients 
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preting the context of the questions that were divided 
into each domain. The fi ve domains into which the 24 
questions were divided were designated as: (1) lower 
extremity function, (2) quality of life, (3) cervical spine 
function, (4) bladder function, and (5) upper extremity 
function. Then the equations to calculate the score for 
each domain were assembled in order to intuitively indi-
cate the status of patients in the fi ve different functional 
domains. The numbers prefi xed to the answers chosen 
by the patients were multiplied by the coeffi cients so 
that the difference between the minimum score repre-
senting the worst condition and the maximum score 
representing the best condition would become 100. The 
equations were further manipulated by other supple-
mental coeffi cients so that the minimum score became 
0 and the maximum score became 100 to make recogni-
tion of the status of the patient as intuitive as possible.
Because the previous JOA scoring system was a 
preference-based system, and the scores for different 
neurological functions (i.e., upper and lower extremity 
motor function, upper and lower extremity and trunk 
sensory function, and bladder function) were added up 
to represent overall status of the patients by one simple 
score, the new system was initially supposed to use a 
similar manner. However, because the fi ve factors 
derived from factor analysis were completely indepen-
dent statistically, and it was considered impractical to 
evaluate the multidimensional aspects of the patient 
suffering cervical myelopathy by one digit, we decided 
to use the scores in different domains independently 
without simply adding them.
We have successfully assembled the fi nal question-
naire that is capable of demonstrating the status of the 
patient suffering cervical myelopathy in fi ve different 
functional aspects with fi ve intuitive numerical scores, 
after rigorous yet sophisticated statistical analyses. The 
remaining issue to be confi rmed is the responsiveness 
of this fi nalized questionnaire against the changes in 
patient status after various surgical and nonsurgical 
treatments. We have investigated if the changes in the 
patient functional status after surgical treatment would 
be accurately refl ected by the changes in the scores in 
the different domains. The results will be shown and 
discussed in part V of our study.
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